Cite
Using of deferasirox and deferoxamine in refractory iron overload thalassemia
MLA
Nattee Narkbunnam, et al. “Using of Deferasirox and Deferoxamine in Refractory Iron Overload Thalassemia.” Pediatrics International : Official Journal of the Japan Pediatric SocietyReferences, vol. 63, no. 4, June 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0ae4ef353710283393b0e18e3a6fc602&authtype=sso&custid=ns315887.
APA
Nattee Narkbunnam, Jassada Buaboonnam, Chayamon Takpradit, Bunchoo Pongtanakul, Vip Viprakasit, Kamon Phuakpet, Nassawee Vathana, & Kleebsabai Sanpakit. (2020). Using of deferasirox and deferoxamine in refractory iron overload thalassemia. Pediatrics International : Official Journal of the Japan Pediatric SocietyReferences, 63(4).
Chicago
Nattee Narkbunnam, Jassada Buaboonnam, Chayamon Takpradit, Bunchoo Pongtanakul, Vip Viprakasit, Kamon Phuakpet, Nassawee Vathana, and Kleebsabai Sanpakit. 2020. “Using of Deferasirox and Deferoxamine in Refractory Iron Overload Thalassemia.” Pediatrics International : Official Journal of the Japan Pediatric SocietyReferences 63 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0ae4ef353710283393b0e18e3a6fc602&authtype=sso&custid=ns315887.